Business Context and Reporting Period
This Form 8-K was filed by Miragen Therapeutics, Inc. (trading symbol: MGEN) on April 27, 2020, reporting events occurring as early as April 21, 2020. The filing discloses the entry into a material definitive agreement involving a loan under the Paycheck Protection Program (PPP).
Key Financial Metrics
- PPP Loan Amount: $1,725,585 received from Silicon Valley Bank.
- Interest Rate: 1.0% per annum.
- Loan Term: Two years, with principal and interest payments deferred for the first six months.
- Existing Debt: As of December 31, 2019, the company had $7.7 million in outstanding debt principal obligations under a separate agreement with Silicon Valley Bank.
- Revenue/Profit/Cash Flow: The filing text does not provide specific values for revenue, profit, operating cash flow, or margins for the current period.
Material Changes
The primary material change is the acquisition of the $1,725,585 PPP loan. This increases the company's total debt obligations, though the loan carries a potential for full or partial forgiveness if proceeds are used for eligible expenses (primarily payroll) within the covered eight-week period following origination. The filing notes that at least 75% of the loan amount must be used for eligible payroll costs to qualify for forgiveness.
Outlook, Risks, and Contingencies
- Forgiveness Uncertainty: The company explicitly states it can provide no assurance that it will obtain forgiveness of the PPP Loan in whole or in part.
- Repayment Obligation: If not forgiven, the company is obligated to make equal monthly payments of principal and interest after the six-month deferral period.
- Events of Default: The note includes standard events of default, including failure to pay, bankruptcy, material adverse changes in financial condition, or failure to disclose material facts to the lender or SBA.
- Prepayment: The note may be prepaid in part or in full at any time without penalty.
Investor Verification Checklist
- Verify the company's actual utilization of loan proceeds against the 75% payroll cost requirement for forgiveness eligibility.
- Review the full text of the Promissory Note (Exhibit 10.1) for specific covenants and default triggers.
- Assess the company's total liquidity position considering the new loan alongside the existing $7.7 million debt obligation.
- Monitor future filings for updates on the SBA's forgiveness determination process.